CLBTCellebrite DI Ltd.

Nasdaq cellebrite.com


$ 16.79 $ 0.22 (1.33 %)    

Thursday, 12-Sep-2024 13:23:56 EDT
QQQ $ 472.35 $ 3.72 (0.79 %)
DIA $ 410.93 $ 1.47 (0.36 %)
SPY $ 557.98 $ 2.99 (0.54 %)
TLT $ 99.72 $ -0.65 (-0.65 %)
GLD $ 235.70 $ 1.06 (0.45 %)
$ 16.64
$ 16.57
$ 16.79 x 200
$ 16.80 x 100
$ 16.57 - $ 16.84
$ 6.37 - $ 17.48
747,389
na
3.42B
$ 0.95
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 cellebrite-di-announces-the-redemption-fair-market-value-for-the-redemption-of-its-warrants-allowing-holders-to-exercise-for-010-per-warrant-or-on-a-cashless-basis-for-0342-ordinary-shares-per-warrant-before-september-16-2024

Cellebrite DI Ltd. (NASDAQ:CLBT) ("Cellebrite," the "Company" or "we"), a global leader in premier Digi...

 deutsche-bank-maintains-buy-on-cellebrite-di-raises-price-target-to-18

Deutsche Bank analyst Jamie Shelton maintains Cellebrite DI (NASDAQ:CLBT) with a Buy and raises the price target from $15 to...

 b-of-a-securities-maintains-buy-on-cellebrite-di-raises-price-target-to-17

B of A Securities analyst Tal Liani maintains Cellebrite DI (NASDAQ:CLBT) with a Buy and raises the price target from $13 to...

 jp-morgan-maintains-overweight-on-cellebrite-di-raises-price-target-to-17

JP Morgan analyst Brian Essex maintains Cellebrite DI (NASDAQ:CLBT) with a Overweight and raises the price target from $15 t...

 lake-street-maintains-buy-on-cellebrite-di-raises-price-target-to-17

Lake Street analyst Frank Takkinen maintains Cellebrite DI (NASDAQ:CLBT) with a Buy and raises the price target from $13.5 t...

 craig-hallum-maintains-buy-on-cellebrite-di-raises-price-target-to-20

Craig-Hallum analyst Jeff Van Rhee maintains Cellebrite DI (NASDAQ:CLBT) with a Buy and raises the price target from $16 to ...

 needham-maintains-buy-on-cellebrite-di-raises-price-target-to-17

Needham analyst Mike Cikos maintains Cellebrite DI (NASDAQ:CLBT) with a Buy and raises the price target from $14 to $17.

 cellebrite-di-q2-2024-adj-eps-010-beats-005-estimate-sales-95714m-beat-91963m-estimate

Cellebrite DI (NASDAQ:CLBT) reported quarterly earnings of $0.10 per share which beat the analyst consensus estimate of $0.05 b...

 jp-morgan-maintains-overweight-on-cellebrite-di-raises-price-target-to-15

JP Morgan analyst Brian Essex maintains Cellebrite DI (NASDAQ:CLBT) with a Overweight and raises the price target from $14 t...

 fbi-reportedly-used-israel-based-security-firms-unreleased-technology-to-crack-trump-shooters-phone

Despite having a license for Cellebrite's software, the FBI's Pittsburgh bureau was unable to bypass the passcode on Cr...

 jp-morgan-maintains-overweight-on-cellebrite-di-raises-price-target-to-14

JP Morgan analyst Brian Essex maintains Cellebrite DI (NASDAQ:CLBT) with a Overweight and raises the price target from $12 t...

 needham-maintains-buy-on-cellebrite-di-raises-price-target-to-14

Needham analyst Mike Cikos maintains Cellebrite DI (NASDAQ:CLBT) with a Buy and raises the price target from $13.5 to $14.

 why-software-company-cellebrite-shares-are-up-today

Cellebrite DI reported strong Q1 FY24 results with revenue up 26% YoY, ARR at $331.8 million, and EPS beating consensus. Outloo...

 cellebrite-di-q1-2024-adj-eps-008-beats-006-estimate-sales-89582m-beat-87757m-estimate

Cellebrite DI (NASDAQ:CLBT) reported quarterly earnings of $0.08 per share which beat the analyst consensus estimate of $0.06 b...

 lake-street-initiates-coverage-on-cellebrite-di-with-buy-rating-announces-price-target-of-13

Lake Street analyst Frank Takkinen initiates coverage on Cellebrite DI (NASDAQ:CLBT) with a Buy rating and announces Price T...

 craig-hallum-maintains-buy-on-cellebrite-di-raises-price-target-to-16

Craig-Hallum analyst Jeff Van Rhee maintains Cellebrite DI (NASDAQ:CLBT) with a Buy and raises the price target from $14 to ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION